Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endocrine Disorders of Female Reproductive System”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06421935
What this trial is testing

M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 60
Not applicableUnknownNCT04528940
What this trial is testing

Tumor Grade Determines PD-1/PDL-1 Expression

Who this might be right for
Endometrial CancerOvarian Cancer
RWJ Barnabas Health at Jersey City Medical Center 100
Post-approval studies (Phase 4)Study completedNCT00795808
What this trial is testing

PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With Clomiphene

Who this might be right for
Polycystic Ovary Syndrome
University of Auckland, New Zealand 171
Testing effectiveness (Phase 2)Study completedNCT06087289
What this trial is testing

Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Novakand Pharma AB 18
Early research (Phase 1)Looking for participantsNCT06885697
What this trial is testing

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Who this might be right for
MesotheliomaNeoplasmsStomach Neoplasms+5 more
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Ended earlyNCT03933813
What this trial is testing

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

Who this might be right for
Epithelial Ovarian CancerAnemiaIron Deficiency Anemia
University of Wisconsin, Madison 9
Early research (Phase 1)Study completedNCT02146313
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmsOvarian Neoplasms
Genentech, Inc. 35
Early research (Phase 1)Ended earlyNCT00637390
What this trial is testing

A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
University of Michigan Rogel Cancer Center 3
Not applicableStudy completedNCT00340210
What this trial is testing

Extended Follow-up of Columbia, MO Serum Bank Participants

Who this might be right for
Breast CancerEndometrial CancerOvarian Cancer
National Cancer Institute (NCI) 6,720
Not applicableLooking for participantsNCT06392997
What this trial is testing

Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology

Who this might be right for
Gynecologic DiseaseGynecologic CancerEndometriosis+5 more
ZIWIG 2,500
Testing effectiveness (Phase 2)Study completedNCT01001910
What this trial is testing

Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Albert Einstein College of Medicine 22
Large-scale testing (Phase 3)Study completedNCT00262990
What this trial is testing

Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
Novartis Pharmaceuticals 829
Testing effectiveness (Phase 2)Ended earlyNCT00331422
What this trial is testing

Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 7
Early research (Phase 1)Ended earlyNCT05061537
What this trial is testing

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Renal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more
Pfizer 13
Early research (Phase 1)Study completedNCT01975831
What this trial is testing

Evaluate MEDI4736 in Combination With Tremelimumab

Who this might be right for
Breast CancerOvarian CancerColorectal Cancer+2 more
Ludwig Institute for Cancer Research 104
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Testing effectiveness (Phase 2)Ended earlyNCT04377087
What this trial is testing

Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Sarah E Taylor 3
Early research (Phase 1)Ended earlyNCT06466187
What this trial is testing

SGN-MesoC2 in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Adenocarcinoma+4 more
Seagen, a wholly owned subsidiary of Pfizer 19
Not applicableUnknownNCT02292914
What this trial is testing

Prospective Analysis of Robot-Assisted Surgery

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+7 more
Instituto do Cancer do Estado de São Paulo 1,120
Not applicableEnded earlyNCT01744821
What this trial is testing

Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Northwestern University 7
Next Page